Lupin acquires Japan's I'rom PharmaceuticalIllustrative image – not actual.

Lupin has acquired Japan's I'rom Pharmaceutical (IP) for an undisclosed sum.

The company's Japan based subsidiary Kyowa Pharmaceutical Industry Co has signed an agreement with I'rom Holdings (IH), an integrated healthcare provider to acquire up to 100 per cent of the outstanding shares of its subsidiary, IP. I'rom Pharmaceutical is a specialty injectables company. The acquisition will not only strengthen Lupin's presence in the Japanese market but would also provide for a stronger growth footprint in this priority market.

 

← All latest storiesBack to top →